0001720725-17-000001.txt : 20171025 0001720725-17-000001.hdr.sgml : 20171025 20171025143923 ACCESSION NUMBER: 0001720725-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171025 DATE AS OF CHANGE: 20171025 EFFECTIVENESS DATE: 20171025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oyster Point Pharma, Inc. CENTRAL INDEX KEY: 0001720725 IRS NUMBER: 811030955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-297412 FILM NUMBER: 171152859 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 949.729.4500 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 D 1 primary_doc.xml X0708 D LIVE 0001720725 Oyster Point Pharma, Inc. ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA CALIFORNIA 94104 949.729.4500 DELAWARE None None Corporation true 2015 William J Link c/o Oyster Point Pharma, Inc. One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Director Ali Behbahani c/o Oyster Point Pharma, Inc. One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Director D. Michael Ackermann c/o Oyster Point Pharma, Inc. One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Director Mark A. Murray c/o Oyster Point Pharma, Inc. One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Executive Officer Director Jeffrey Nau c/o Oyster Point Pharma, Inc. One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2017-10-11 false true false 0 43125784 28614800 14510984 false 8 0 0 0 false Oyster Point Pharma, Inc. /s/Jeffrey Nau Jeffrey Nau President and Chief Executive Officer 2017-10-24